MRK - Merus rallies on publication of oncology study abstracts
2024-05-24 09:36:39 ET
More on Merus
- Merus: Positive Zenocutuzumab Data In 2024 Could Provide BLA Advancement
- Merus gets FDA breakthrough therapy status for petosemtamab
- FDA accepts Merus application for Zeno for lung, pancreatic cancer
- Seeking Alpha’s Quant Rating on Merus
- Historical earnings data for Merus